Preparation carried with particles of antitumor drug and preparation method thereof
A technology of anti-tumor drugs and microparticles, which is applied in the direction of anti-tumor drugs, medical preparations of non-active ingredients, drug combinations, etc., can solve problems such as necrosis of mesenchymal stem cells, achieve improved curative effect, broad application prospects, and reduce toxic and side effects Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Example 1 Formulation carrying doxorubicin hydrochloride microparticles
[0033] a. Preparation of antitumor drug particles: prepared by emulsification-solvent evaporation method. The preparation process is as follows: doxorubicin hydrochloride and PLA are dissolved in DMSO to form an organic phase. The above-mentioned organic phase is emulsified by ultrasound in the pH 7.4 phosphate buffer solution containing PVA205, and the organic solvent is quickly evaporated by drying under reduced pressure to prepare doxorubicin hydrochloride PLA with an average particle size of 120nm and a drug content of 2.5%. particle.
[0034] b. Preparation of multidrug-resistant mesenchymal stem cells expressing P-glycoprotein: using retrovirus as a vector, transfecting the multidrug resistance gene into mesenchymal stem cells to obtain multidrug-resistant mesenchymal stem cells expressing P-glycoprotein Stem cells, spare.
[0035] The preparation process is as follows: pMX-mdr1-GFP and o...
Embodiment 2
[0037] Example 2 Formulations carrying paclitaxel microparticles
[0038] a. Preparation of antitumor drug particles: prepared by emulsification-solvent evaporation method. The preparation process is as follows: dissolving paclitaxel and PLA in dichloromethane to form an organic phase. The above-mentioned organic phase is emulsified by ultrasound in a pH 7.4 phosphate buffer containing Tween 80, and the organic solvent is quickly evaporated by drying under reduced pressure to prepare paclitaxel PLA particles with an average particle size of 95nm and a drug content of 4.1%.
[0039] b. Preparation of P-glycoprotein-expressing multidrug-resistant mesenchymal stem cells: using lentivirus as a vector, the multidrug-resistant mesenchymal stem cells were transfected with multidrug resistance genes to obtain P-glycoprotein-expressing multidrug-resistant mesenchymal stem cells Stem cells, ready for use; the preparation process is as follows: using lipofection method, pMX-mdr1-GFP and...
Embodiment 3
[0041] Example 3 Formulations carrying docetaxel microparticles
[0042] a. Preparation of antitumor drug particles: prepared by emulsification-solvent evaporation method. The preparation process is as follows: docetaxel and PLGA are dissolved in acetone to form an organic phase. The above-mentioned organic phase is emulsified by ultrasonic wave in the pH 7.4 phosphate buffer solution containing Poloxamer 188, and the organic solvent is quickly evaporated in the mode of drying under reduced pressure. Cetaxel PLGA microparticles, wherein the molar ratio of propiolactone to acetolactone in PLGA is 1 / 99;
[0043] b. Preparation of multidrug-resistant mesenchymal stem cells expressing P-glycoprotein: using retrovirus as a vector, transfecting the multidrug resistance gene into mesenchymal stem cells to obtain multidrug-resistant mesenchymal stem cells expressing P-glycoprotein Stem cells, spare;
[0044] The preparation process is as follows: pMX-mdr1-GFP and outer membrane pro...
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com